No abstract available
Keywords:
amphiregulin (AREG); cyclic adenosine monophosphate (cAMP); epidermal growth factor receptor (EGFR); phosphodiesterase 3A; renoprotection.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Cyclic Nucleotide Phosphodiesterases, Type 3
-
Epidermal Growth Factor*
-
ErbB Receptors
-
Humans
-
Hypertension* / complications
-
Kidney
Substances
-
Cyclic Nucleotide Phosphodiesterases, Type 3
-
Epidermal Growth Factor
-
ErbB Receptors